Yasunobu Sekiguchi¹, Mutsumi Wakabayashi¹, Haruko Takizawa¹, Hiroko Iizuka¹, Sakura Sakajiri¹, Keiji Sugimoto¹, Hiroshi Izumi², Shigeki Tomita², Mitsuo Okubo³, Tomohiro Sawada⁴, Norio Komatsu⁵, Masaaki Noguchi¹ (1.Department of Hematology, Juntendo University Urayasu Hospital., Chiba, Japan, 2.Department of Pathology, Juntendo University Urayasu Hospital., Chiba, Japan, 3.Department of Blood Transfusion, Juntendo University Urayasu Hospital., Chiba, Japan, 4.Department of Clinical Laboratory, Juntendo University Urayasu Hospital., Chiba, Japan, 5.Department of Hematology, Juntendo University Juntendo Hospital., Tokyo, Japan)

Yoshihisa Mizukami^1,2, Marito Araki^1,3, Misa Imai^1,4, Erina Hayashi¹, Nami Masubuchi^1,5, Yinjie Yang¹, Yoshihiko Kihara^1,4, Yumi Hironaka¹, Akimichi Ohsaka³, Norio Komatsu¹ (1.Hematol., Juntendo Univ., Tokyo, Japan, 2.Center for Genomic and Regenerative Med., Juntendo Univ., Tokyo, Japan, 3.Transfusion Med and Stem Cell Regulation., Juntendo Univ., Tokyo, Japan, 4.Leading Center, Development Research Cancer Med., Juntendo Univ., Tokyo, Japan, 5.Research Institute, Disease of Old Age., Juntendo Univ., Tokyo, Japan)

Misa Imai¹, Yasutaka Fukuda¹, Teppei Taguchi¹, Kyohei Misawa¹, Honglian Tong¹, Kimi Araki², Motomi Osato^3,4, Marito Araki⁵, Akimichi Ohsaka⁵, Norio Komatsu¹ (1.Dept Hemat, Juntendo Univ., Tokyo, Japan, 2.IRDA, Kumamoto Univ., Kumamoto, Japan, 3.IRCMS, Kumamoto Univ., Kumamoto, Japan, 4.CSI, National University of Singapore, Singapore, 5.Dept Transfus Med & Stem Cell Reg, Juntendo Univ, Tokyo Japan)

Norio Komatsu¹, GyungJin Jun², Toshio Yonezu², Yasuo Ohashi³ (1.Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan, 2.Novartis Pharma KK, Tokyo, Japan, 3.Integrated Science and Engineering for Sustainable Society, Chuo University, Tokyo, Japan)

Shunichiro Yasuda^1,2, Satoru Aoyama^1,2, Ryouto Yoshimoto², Daisuke Watanabe^1,2, Kouhei Yamamoto³, Yoko Edahiro⁵, Marito Araki⁴, Norio Komatsu⁵, Osamu Miura², Norihiko Kawamata¹ (1.Department of Immunotherapy for Hematopoietic Disorders, TMDU, Tokyo, Japan, 2.Department of Hematology, TMDU, Tokyo, Japan, 3.Department of Comprehensive pathology, TMDU, Tokyo, Japan, 4.Transfusion Medicine and Stem Cell Regulation, Juntendo university, Tokyo, Japan, 5.Department of Hematology, Juntendo university, Tokyo, Japan)

Luan Cao-Sy^1,2, Yoshiali Takahoko¹, Naoshi Obara¹, Tatsuhiro Sakamoto¹, Takayasu Kato¹, Keiichiro Hattori¹, Ryota Matsuoka³, Shingo Sakashita³, Yasuhito Nanya⁴, Seishi Ogawa⁴, Mamiko Sakata-Yanagimoto¹, Hidekazu Nishikii¹, Shigeru Chiba¹ (1.Department of Hematology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan, 2.Department of Molecular Cytogenetics, Blood Transfusion Hematology Hospital, Ho Chi Minh, Socialist Republic of Viet Nam, 3.Department of Pathology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan, 4.Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan)

Sung Hwa Bae, A-Jin Lee, Jun Yeb Nam, Sang-Gyung Kim (Daegu Catholic University Hospital, Daegu, Republic of Korea)

Toshikage Nagao, Tohru Aoyama, Ayako Nogami, Yoshihiro Umezawa, Masahide Yamamoto, Norihiko Kawamata, Osamu Miura (Hematol., Tokyo Med Dent Univ., Tokyo, Japan)